{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:03:27Z","timestamp":1777982607028,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s11060-026-05452-3","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T14:38:31Z","timestamp":1770215911000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Carmustine wafer implantation in epileptic seizures of newly diagnosed glioblastomas, IDH-wildtype in adults"],"prefix":"10.1007","volume":"176","author":[{"given":"Alexandre","family":"Roux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Elia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Nadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benoit","family":"Hudelist","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzague","family":"Defrance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elias Al","family":"Helou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kor Gael","family":"Toruslu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Dezamis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Parraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Oppenheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrice","family":"Chretien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Zanello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johan","family":"Pallud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,4]]},"reference":[{"key":"5452_CR1","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","volume":"23","author":"DN Louis","year":"2021","unstructured":"Louis DN, Perry A, Wesseling P et al (2021) The 2021 WHO classification of tumors of the central nervous system: a summary. Neuro-Oncol 23:1231\u20131251. https:\/\/doi.org\/10.1093\/neuonc\/noab106","journal-title":"Neuro-Oncol"},{"key":"5452_CR2","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.1016\/S1470-2045(24)00130-X","volume":"25","author":"P Karschnia","year":"2024","unstructured":"Karschnia P, Gerritsen JKW, Teske N et al (2024) The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a review by the RANO resect group. Lancet Oncol 25:e404\u2013e419. https:\/\/doi.org\/10.1016\/S1470-2045(24)00130-X","journal-title":"Lancet Oncol"},{"key":"5452_CR3","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1093\/neuonc\/noac193","volume":"25","author":"P Karschnia","year":"2023","unstructured":"Karschnia P, Young JS, Dono A et al (2023) Prognostic validation of a new classification system for extent of resection in glioblastoma: A report of the RANO resect group. Neuro-Oncol 25:940\u2013954. https:\/\/doi.org\/10.1093\/neuonc\/noac193","journal-title":"Neuro-Oncol"},{"key":"5452_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2019.6143","author":"AM Molinaro","year":"2020","unstructured":"Molinaro AM, Hervey-Jumper S, Morshed RA et al (2020) Association of maximal extent of resection of Contrast-Enhanced and Non-Contrast-Enhanced tumor with survival within molecular subgroups of patients with newly diagnosed glioblastoma. JAMA Oncol. https:\/\/doi.org\/10.1001\/jamaoncol.2019.6143","journal-title":"JAMA Oncol"},{"key":"5452_CR5","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1016\/S0140-6736(95)90755-6","volume":"345","author":"H Brem","year":"1995","unstructured":"Brem H, Piantadosi S, Burger PC et al (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain tumor treatment group. Lancet Lond Engl 345:1008\u20131012","journal-title":"Lancet Lond Engl"},{"key":"5452_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1215\/S1522-8517-02-00023-6","volume":"5","author":"M Westphal","year":"2003","unstructured":"Westphal M, Hilt DC, Bortey E et al (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro-Oncol 5:79\u201388. https:\/\/doi.org\/10.1215\/S1522-8517-02-00023-6","journal-title":"Neuro-Oncol"},{"key":"5452_CR7","doi-asserted-by":"publisher","unstructured":"Roux A, Elia A, Aboubakr O et al (2024) Efficacy and safety of carmustine wafer implantation after ventricular opening in Glioblastomas, isocitrate Dehydrogenase-Wildtype, in adults. https:\/\/doi.org\/10.1227\/neu.0000000000002817. Neurosurgery","DOI":"10.1227\/neu.0000000000002817"},{"key":"5452_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00701-005-0707-z","volume":"148","author":"M Westphal","year":"2006","unstructured":"Westphal M, Ram Z, Riddle V et al (2006) Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir (Wien) 148:269\u2013275 discussion 275. https:\/\/doi.org\/10.1007\/s00701-005-0707-z","journal-title":"Acta Neurochir (Wien)"},{"key":"5452_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3171\/2008.5.17557","volume":"110","author":"MJ McGirt","year":"2009","unstructured":"McGirt MJ, Than KD, Weingart JD et al (2009) Gliadel (BCNU) wafer plus concomitant Temozolomide therapy after primary resection of glioblastoma multiforme. J Neurosurg 110:583\u2013588. https:\/\/doi.org\/10.3171\/2008.5.17557","journal-title":"J Neurosurg"},{"key":"5452_CR10","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1245\/s10434-008-0048-2","volume":"15","author":"FJ Attenello","year":"2008","unstructured":"Attenello FJ, Mukherjee D, Datoo G et al (2008) Use of gliadel (BCNU) wafer in the surgical treatment of malignant glioma: a 10-year institutional experience. Ann Surg Oncol 15:2887\u20132893. https:\/\/doi.org\/10.1245\/s10434-008-0048-2","journal-title":"Ann Surg Oncol"},{"key":"5452_CR11","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1245\/s10434-010-1081-5","volume":"17","author":"P Menei","year":"2010","unstructured":"Menei P, Metellus P, Parot-Schinkel E et al (2010) Biodegradable carmustine wafers (Gliadel) alone or in combination with chemoradiotherapy: the French experience. Ann Surg Oncol 17:1740\u20131746. https:\/\/doi.org\/10.1245\/s10434-010-1081-5","journal-title":"Ann Surg Oncol"},{"key":"5452_CR12","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1093\/neuonc\/nov126","volume":"17","author":"J Pallud","year":"2015","unstructured":"Pallud J, Audureau E, Noel G et al (2015) Long-term results of carmustine wafer implantation for newly diagnosed glioblastomas: a controlled propensity-matched analysis of a French multicenter cohort. Neuro-Oncol 17:1609\u20131619. https:\/\/doi.org\/10.1093\/neuonc\/nov126","journal-title":"Neuro-Oncol"},{"key":"5452_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-017-2551-4","author":"A Roux","year":"2017","unstructured":"Roux A, Peeters S, Zanello M et al (2017) Extent of resection and carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice. J Neurooncol. https:\/\/doi.org\/10.1007\/s11060-017-2551-4","journal-title":"J Neurooncol"},{"key":"5452_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11060-020-03410-1","volume":"147","author":"C Champeaux","year":"2020","unstructured":"Champeaux C, Weller J (2020) Implantation of carmustine wafers (Gliadel\u00ae) for high-grade glioma treatment. A 9-year nationwide retrospective study. J Neurooncol 147:159\u2013169. https:\/\/doi.org\/10.1007\/s11060-020-03410-1","journal-title":"J Neurooncol"},{"key":"5452_CR15","doi-asserted-by":"publisher","first-page":"vdab189","DOI":"10.1093\/noajnl\/vdab189","volume":"4","author":"T Iuchi","year":"2022","unstructured":"Iuchi T, Inoue A, Hirose Y et al (2022) Long-term effectiveness of gliadel implant for malignant glioma and prognostic factors for survival: 3-year results of a postmarketing surveillance in Japan. Neuro-Oncol Adv 4:vdab189. https:\/\/doi.org\/10.1093\/noajnl\/vdab189","journal-title":"Neuro-Oncol Adv"},{"key":"5452_CR16","volume-title":"NICE guidance on cancer services: improving outcomes for people with brain and other CNS tumours: the Manaual","author":"National Institute for Health and Clinical Excellence","year":"2006","unstructured":"National Institute for Health and Clinical Excellence (2006) NICE guidance on cancer services: improving outcomes for people with brain and other CNS tumours: the Manaual. National Institute for Health and Clinical Excellence, London"},{"key":"5452_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007294","author":"MG Hart","year":"2008","unstructured":"Hart MG, Grant R, Garside R et al (2008) Chemotherapeutic wafers for high grade glioma. Cochrane Database Syst Rev CD007294. https:\/\/doi.org\/10.1002\/14651858.CD007294","journal-title":"Cochrane Database Syst Rev CD007294"},{"key":"5452_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007294.pub2","author":"MG Hart","year":"2011","unstructured":"Hart MG, Grant R, Garside R et al (2011) Chemotherapy wafers for high grade glioma. Cochrane Database Syst Rev CD007294. https:\/\/doi.org\/10.1002\/14651858.CD007294.pub2","journal-title":"Cochrane Database Syst Rev CD007294"},{"key":"5452_CR19","doi-asserted-by":"publisher","unstructured":"Roux A, Caire F, Guyotat J et al (2017) Carmustine wafer implantation for high-grade gliomas: Evidence-based safety efficacy and practical recommendations from the Neuro-oncology club of the French society of neurosurgery. https:\/\/doi.org\/10.1016\/j.neuchi.2017.07.003. Neurochirurgie","DOI":"10.1016\/j.neuchi.2017.07.003"},{"key":"5452_CR20","doi-asserted-by":"publisher","first-page":"e207902","DOI":"10.1212\/WNL.0000000000207902","volume":"102","author":"J Pallud","year":"2024","unstructured":"Pallud J, Roux A, Moiraghi A et al (2024) Characteristics and prognosis of tumor-Related epilepsy during tumor evolution in patients with IDH Wild-Type glioblastoma. Neurology 102:e207902. https:\/\/doi.org\/10.1212\/WNL.0000000000207902","journal-title":"Neurology"},{"key":"5452_CR21","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2176\/nmc.oa2013-0112","volume":"54","author":"T Aoki","year":"2014","unstructured":"Aoki T, Nishikawa R, Sugiyama K et al (2014) A multicenter phase I\/II study of the BCNU implant (Gliadel(\u00ae) Wafer) for Japanese patients with malignant gliomas. Neurol Med Chir (Tokyo) 54:290\u2013301","journal-title":"Neurol Med Chir (Tokyo)"},{"key":"5452_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3109\/02688697.2010.550342","volume":"25","author":"S Dixit","year":"2011","unstructured":"Dixit S, Hingorani M, Achawal S, Scott I (2011) The sequential use of carmustine wafers (Gliadel\u00ae) and post-operative radiotherapy with concomitant Temozolomide followed by adjuvant Temozolomide: a clinical review. Br J Neurosurg 25:459\u2013469. https:\/\/doi.org\/10.3109\/02688697.2010.550342","journal-title":"Br J Neurosurg"},{"key":"5452_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/00006123-199707000-00011","volume":"41","author":"S Valtonen","year":"1997","unstructured":"Valtonen S, Timonen U, Toivanen P et al (1997) Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 41:44\u201348 discussion 48\u201349","journal-title":"Neurosurgery"},{"key":"5452_CR24","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1245\/s10434-012-2764-x","volume":"20","author":"J Duntze","year":"2013","unstructured":"Duntze J, Litr\u00e9 C-F, Eap C et al (2013) Implanted carmustine wafers followed by concomitant radiochemotherapy to treat newly diagnosed malignant gliomas: prospective, observational, multicenter study on 92 cases. Ann Surg Oncol 20:2065\u20132072. https:\/\/doi.org\/10.1245\/s10434-012-2764-x","journal-title":"Ann Surg Oncol"},{"key":"5452_CR25","first-page":"17","volume":"45","author":"BR Subach","year":"1999","unstructured":"Subach BR, Witham TF, Kondziolka D et al (1999) Morbidity and survival after 1,3-bis(2-chloroethyl)-1-nitrosourea wafer implantation for recurrent glioblastoma: a retrospective case-matched cohort series. Neurosurgery 45:17\u201322 discussion 22\u201323","journal-title":"Neurosurgery"},{"key":"5452_CR26","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant Temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. https:\/\/doi.org\/10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"5452_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","volume":"10","author":"R Stupp","year":"2009","unstructured":"Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant Temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol 10:459\u2013466. https:\/\/doi.org\/10.1016\/S1470-2045(09)70025-7","journal-title":"Lancet Oncol"},{"key":"5452_CR28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1227\/NEU.0b013e318223f5a7","volume":"70","author":"MA Vogelbaum","year":"2012","unstructured":"Vogelbaum MA, Jost S, Aghi MK et al (2012) Application of novel response\/progression measures for surgically delivered therapies for gliomas: response assessment in Neuro-Oncology (RANO) working group. Neurosurgery 70:234\u2013243 discussion 243\u2013244. https:\/\/doi.org\/10.1227\/NEU.0b013e318223f5a7","journal-title":"Neurosurgery"},{"key":"5452_CR29","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","volume":"55","author":"RS Fisher","year":"2014","unstructured":"Fisher RS, Acevedo C, Arzimanoglou A et al (2014) ILAE official report: a practical clinical definition of epilepsy. Epilepsia 55:475\u2013482. https:\/\/doi.org\/10.1111\/epi.12550","journal-title":"Epilepsia"},{"key":"5452_CR30","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s00401-018-1913-0","volume":"136","author":"DJ Brat","year":"2018","unstructured":"Brat DJ, Aldape K, Colman H et al (2018) cIMPACT-NOW update 3: recommended diagnostic criteria for diffuse astrocytic glioma, IDH-wildtype, with molecular features of glioblastoma, WHO grade IV. Acta Neuropathol (Berl) 136:805\u2013810. https:\/\/doi.org\/10.1007\/s00401-018-1913-0","journal-title":"Acta Neuropathol (Berl)"},{"key":"5452_CR31","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s11060-021-03705-x","volume":"152","author":"V Borger","year":"2021","unstructured":"Borger V, Hamed M, Ilic I et al (2021) Seizure outcome in Temporal glioblastoma surgery: lobectomy as a supratotal resection regime outclasses conventional gross-total resection. J Neurooncol 152:339\u2013346. https:\/\/doi.org\/10.1007\/s11060-021-03705-x","journal-title":"J Neurooncol"},{"key":"5452_CR32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/neuonc\/noad154","volume":"26","author":"EK Avila","year":"2024","unstructured":"Avila EK, Tobochnik S, Inati SK et al (2024) Brain tumor-related epilepsy management: A society for Neuro-oncology (SNO) consensus review on current management. Neuro-Oncol 26:7\u201324. https:\/\/doi.org\/10.1093\/neuonc\/noad154","journal-title":"Neuro-Oncol"},{"key":"5452_CR33","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1186\/s12885-024-13249-8","volume":"24","author":"J Rossi","year":"2024","unstructured":"Rossi J, Cavallieri F, Bassi MC et al (2024) To be or not to be: the dilemma over the prognostic role of epilepsy at presentation in patients with glioblastoma - a systematic review and meta-analysis. BMC Cancer 24:1488. https:\/\/doi.org\/10.1186\/s12885-024-13249-8","journal-title":"BMC Cancer"},{"key":"5452_CR34","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.21873\/invivo.12961","volume":"36","author":"D Rades","year":"2022","unstructured":"Rades D, Witteler J, Trillenberg P et al (2022) Increasing seizure activity during radiation treatment for High-grade Gliomas - Final results of a prospective interventional study. Vivo Athens Greece 36:2308\u20132313. https:\/\/doi.org\/10.21873\/invivo.12961","journal-title":"Vivo Athens Greece"},{"key":"5452_CR35","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/neuonc\/not109","volume":"15","author":"R Rud\u00e0","year":"2013","unstructured":"Rud\u00e0 R, Magliola U, Bertero L et al (2013) Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study. Neuro-Oncol 15:1739\u20131749. https:\/\/doi.org\/10.1093\/neuonc\/not109","journal-title":"Neuro-Oncol"},{"key":"5452_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11060-020-03573-x","volume":"149","author":"SA Climans","year":"2020","unstructured":"Climans SA, Brandes AA, Cairncross JG et al (2020) Temozolomide and seizure outcomes in a randomized clinical trial of elderly glioblastoma patients. J Neurooncol 149:65\u201371. https:\/\/doi.org\/10.1007\/s11060-020-03573-x","journal-title":"J Neurooncol"},{"key":"5452_CR37","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1007\/s00701-012-1413-2","volume":"154","author":"P De Bonis","year":"2012","unstructured":"De Bonis P, Anile C, Pompucci A et al (2012) Safety and efficacy of gliadel wafers for newly diagnosed and recurrent glioblastoma. Acta Neurochir (Wien) 154:1371\u20131378. https:\/\/doi.org\/10.1007\/s00701-012-1413-2","journal-title":"Acta Neurochir (Wien)"},{"key":"5452_CR38","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1185\/03007990802508180","volume":"24","author":"M Sabel","year":"2008","unstructured":"Sabel M, Giese A (2008) Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience. Curr Med Res Opin 24:3239\u20133257. https:\/\/doi.org\/10.1185\/03007990802508180","journal-title":"Curr Med Res Opin"},{"key":"5452_CR39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s11060-021-03792-w","volume":"153","author":"C Bettag","year":"2021","unstructured":"Bettag C, Hussein A, Sachkova A et al (2021) Implantation of carmustine wafers after resection of malignant glioma with and without opening of the ventricular system. J Neurooncol 153:519\u2013525. https:\/\/doi.org\/10.1007\/s11060-021-03792-w","journal-title":"J Neurooncol"},{"key":"5452_CR40","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G et al (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol (Berl) 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol (Berl)"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05452-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05452-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05452-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T10:47:26Z","timestamp":1772102846000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05452-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["5452"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05452-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8523222\/v1","asserted-by":"object"}]},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}